<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Union Minister Shri Piyush Goyal Invites Global Pharma Companies to Partner India&#039;s Growth Story; Says Pharmaceutical Industry Can Double in Next Five Years</title>
    <link>https://www.taxtmi.com/news?id=73240</link>
    <description>India&#039;s pharmaceutical sector is presented as a partner in innovation-led healthcare while continuing to supply affordable medicines globally. Global companies are invited to deepen collaboration through manufacturing, technology, clinical trials, supply chains and market access, with the industry described as capable of significant expansion over the next five years. The sector&#039;s strengths are identified as trust, innovation and partnerships, supported by global manufacturing standards, rising patent filings, and government programmes for research and development. India also emphasises durable cooperation for equitable healthcare access and long-term pharmaceutical supply resilience.</description>
    <language>en-us</language>
    <pubDate>Tue, 09 Jun 2026 09:13:45 +0530</pubDate>
    <lastBuildDate>Tue, 09 Jun 2026 09:13:44 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=906169" rel="self" type="application/rss+xml"/>
    <item>
      <title>Union Minister Shri Piyush Goyal Invites Global Pharma Companies to Partner India&#039;s Growth Story; Says Pharmaceutical Industry Can Double in Next Five Years</title>
      <link>https://www.taxtmi.com/news?id=73240</link>
      <description>India&#039;s pharmaceutical sector is presented as a partner in innovation-led healthcare while continuing to supply affordable medicines globally. Global companies are invited to deepen collaboration through manufacturing, technology, clinical trials, supply chains and market access, with the industry described as capable of significant expansion over the next five years. The sector&#039;s strengths are identified as trust, innovation and partnerships, supported by global manufacturing standards, rising patent filings, and government programmes for research and development. India also emphasises durable cooperation for equitable healthcare access and long-term pharmaceutical supply resilience.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Tue, 09 Jun 2026 09:13:45 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=73240</guid>
    </item>
  </channel>
</rss>